The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Large Is The Female Fertility And Pregnancy Rapid Test Market Projected To Become By 2030 Based On Its 2026 Valuation?
The female fertility and pregnancy rapid test market size has demonstrated significant expansion in recent years. This market is expected to grow from $1.48 billion in 2025 to $1.58 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.2%. The historical increase can be attributed to factors such as heightened awareness regarding female reproductive health, the rising utilization of ovulation predictor kits, improved retail availability of rapid tests, the expansion of hospital-based diagnostic testing, and an increasing prevalence of infertility diagnoses.
The market for female fertility and pregnancy rapid tests is projected to experience significant expansion over the coming years. This market is set to reach a value of $2.05 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.7%. Factors driving this growth include a heightened need for early pregnancy detection, the increasing embrace of digital health monitoring technologies, a greater emphasis on customized fertility management, the broadening scope of diagnostics supported by telehealth, and the expanding presence of healthcare products in e-commerce. Concurrently, key trends anticipated during this period encompass the greater uptake of rapid testing kits for home use, an increasing desire for digital and app-integrated testing devices, the rising utilization of combined fertility and pregnancy tests, the widening of online sales channels, and an intensified focus on designing tests that are both user-friendly and highly accurate.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8966&type=smp
Which Market Drivers Are Supporting The Expansion Of The Female Fertility And Pregnancy Rapid Test Market?
The growing occurrence of gynecological conditions is anticipated to fuel the expansion of the female fertility and pregnancy rapid test market. These conditions are medical issues impacting female reproductive organs, specifically the breasts, abdominal and pelvic organs such as the womb (uterus), ovaries, vagina, fallopian tubes, and vulva. Female fertility and pregnancy rapid tests assist in managing gynecological disorders by allowing for the prompt identification of hormonal imbalances or pregnancy-related problems, thereby facilitating early diagnosis and effective treatment of reproductive health concerns. For example, a May 2025 report from the National Library of Medicine indicated that approximately 61.2% of women encountered at least one gynecological morbidity, with dysmenorrhea being the most prevalent at 61.3%, followed by irregular menses and infertility, both at 36.1%. Consequently, the rising prevalence of gynecological disorders is propelling the growth of the female fertility and pregnancy rapid test market.
What Segment Groups Are Identified Within The Female Fertility And Pregnancy Rapid Test Market?
The female fertility and pregnancy rapid test market covered in this report is segmented –
1) By Product: Fertility Rapid Test Kits, Pregnancy Rapid Test Kits
2) By Device Type: Digital Devices, Line-indicator Devices
3) By Test Type: FSH Urine Test, LH Urine Test, hCG Blood Test, hCG Urine Test
4) By Distribution Channel: Hospital Channel, Retail Channel, Online Channel
Subsegments:
1) By Fertility Rapid Test Kits: Ovulation Predictor Kits, Luteinizing Hormone (LH) Test Kits, Follicle-Stimulating Hormone (FSH) Test Kits
2) By Pregnancy Rapid Test Kits: Urine-Based Pregnancy Tests, Blood-Based Pregnancy Tests, Combo Fertility And Pregnancy Tests
What Trends Are Advancing Progress In The Female Fertility And Pregnancy Rapid Test Market?
Leading companies within the female fertility and pregnancy rapid test market are concentrating on creating novel solutions, including saliva-based home pregnancy tests, to address the increasing need for non-invasive options. Such a test is a lateral-flow, point-of-care assay designed to identify pregnancy biomarkers in oral fluid instead of urine. For example, in May 2024, Abingdon Health plc, a UK-based lateral flow CDMO, introduced the world’s first Boots-branded saliva pregnancy self-test (available both in Boots stores and online), thereby integrating this saliva-based technology into widespread retail. This product comprises a saliva collection interface and a proprietary lateral-flow immunoassay, developed in collaboration with Salignostics and Crest Medical, engineered to bind and show the presence of the pregnancy biomarker in oral fluid; it operates as a quick, single-use self-test delivering results within minutes and is prepared for over-the-counter sale. Distinctively, it eliminates the need for urine collection in the testing process (enhancing comfort and hygiene), promotes consumer acceptance through a familiar “stick/cassette” design, and is purposed for regular home screening and early pregnancy confirmation, benefiting from Boots’ extensive retail presence and consumer confidence.
Which Companies Hold Significant Positions In The Female Fertility And Pregnancy Rapid Test Market?
Major companies operating in the female fertility and pregnancy rapid test market are Abbott Laboratories, Atlas Medical GmbH, bioMérieux SA, Church & Dwight Co. Inc., Quidel Corporation, Egens Group, Eurofins Scientific SE, Everlywell Inc., Genea Pty Limited, Geratherm Medical AG, SA Scientific Ltd., Artron Laboratories Inc., PRIMA Lab SA, The Procter & Gamble Company, Alere Inc., Prestige Brands Holdings Inc., SPD Swiss Precision Diagnostics GmbH, Fairhaven Health LLC, Fertility Focus Limited, HiLin Life Products Inc., Inverness Medical Innovations Inc., UEBE Medical GmbH, Wondfo Biotech Co. Ltd.
Read the full female fertility and pregnancy rapid test market report here:
How Is The Female Fertility And Pregnancy Rapid Test Market Distributed Across Key Geographic Regions?
North America was the largest region in the female fertility and pregnancy rapid test market in 2025. The regions covered in the female fertility and pregnancy rapid test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Female Fertility And Pregnancy Rapid Test Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=8966&type=smp
Browse Through More Reports Similar to the Global Female Fertility And Pregnancy Rapid Test Market 2026, By The Business Research Company
Fertility Treatments Market Report 2026
https://www.thebusinessresearchcompany.com/report/fertility-treatments-global-market-report
Fertility Services Market Report 2026
https://www.thebusinessresearchcompany.com/report/fertility-services-global-market-report
Male Fertility Market Report 2026
https://www.thebusinessresearchcompany.com/report/male-fertility-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model